Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, explains why raising the standard of medical knowledge of artificial intelligence (AI) in ophthalmology is important.
Although the people who understand artificial intelligence (AI) best are data scientists and computer programmers, clinicians are going to be the ones using this technology on their patients, said Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington.
Transcript
How can universities ensure their curriculums evolve at the same pace as technological developments in the ophthalmology field?
So that's actually one of my biggest passions, raising the standard of medical knowledge in this space, because I think it's really lacking. It's a new field. The people who understand it the best, right now, are data scientists and computer programmers and not necessarily clinicians. But the clinicians are going to be the ones who are going to be using it on their patients, and they're going to be responsible for all the good and bad that comes with using AI algorithms to affect the health of another human being.
So, learning how to use AI responsibly and ethically and safely requires understanding some of the fundamentals of artificial intelligence. To do that, it would make sense for it to be integrated into medical school curriculums or into residency training itself. I know in the field of radiology, for instance, there's quite a bit of emphasis placed into understanding how artificial intelligence, and, specifically, how deep learning works because their field has transformed so much due to that technology. I think it makes sense for the same thing to happen in the ophthalmology space as well, because our space may actually be ahead of radiology in certain ways of how AI will be used in clinical care.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More